RecruitingNCT04518592

Model-based Defining of Subtypes of Depression and Optimal Treatment: an Integrated Techniques Module.

Model-based Defining of Subtypes of Depression and Optimal Treatment: an Integrated Techniques Module in Multidimensional Omics for Peripheral Biomarkers.


Sponsor

Shanghai Mental Health Center

Enrollment

300 participants

Start Date

Dec 22, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

In this proposal, the investigators aim to explore the clinical subtypes and biological markers to personalize the use of antidepressants in MDD. By stratifying the subjects with (versus without) remission and treatment response, the biological markers are expected to have important prediction effects in future clinical practice.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is using brain imaging and biological tests to identify specific subtypes of severe depression in order to match patients to the most effective treatment for their type. **You may be eligible if...** - You are between 18 and 65 years old - You have been diagnosed with severe major depressive disorder (single or recurrent episode) - Your depression score on a standard rating scale is high (MADRS ≥24) - You are not currently pregnant **You may NOT be eligible if...** - You have bipolar disorder, psychosis, or schizophrenia - You have a serious neurological condition such as epilepsy or dementia - You have significant heart, liver, or kidney disease - You are currently at high risk of suicide requiring immediate hospitalization Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04518592


Related Trials